SYSTEM AND METHOD FOR INPUTTING CHARACTERS IN TOUCH-BASED ELECTRONIC DEVICE
    1.
    发明申请
    SYSTEM AND METHOD FOR INPUTTING CHARACTERS IN TOUCH-BASED ELECTRONIC DEVICE 有权
    用于在基于触摸的电子设备中输入字符的系统和方法

    公开(公告)号:US20130033444A1

    公开(公告)日:2013-02-07

    申请号:US13561748

    申请日:2012-07-30

    IPC分类号: G06F3/041 G06F3/01

    CPC分类号: G06F3/018 G06F3/04883

    摘要: A character input system and method is provided that enables a user to input and edit block characters via a touch-based electronic device, with a limited number of input motions. The character input method includes receiving a first interaction, displaying a first character in response to the first interaction, receiving a second interaction successively after the first interaction, identifying a second character that is formed by combining the first character with a character according to the second interaction, and displaying the second character instead of the first character.

    摘要翻译: 提供了一种字符输入系统和方法,其使用户能够通过基于触摸的电子设备以有限数量的输入运动来输入和编辑块字符。 字符输入方法包括接收第一交互,响应于第一交互显示第一字符,在第一交互之后连续地接收第二交互,识别通过根据第二交互组合第一字符与字符形成的第二字符 交互,并显示第二个字符而不是第一个字符。

    METHOD AND APPARATUS FOR PROVIDING CHARACTER INPUT INTERFACE
    4.
    发明申请
    METHOD AND APPARATUS FOR PROVIDING CHARACTER INPUT INTERFACE 有权
    用于提供字符输入接口的方法和装置

    公开(公告)号:US20120313858A1

    公开(公告)日:2012-12-13

    申请号:US13436065

    申请日:2012-03-30

    IPC分类号: G06F3/02

    摘要: A method and an apparatus for providing a character input interface are provided. The method for providing a character input interface in a terminal having a touchscreen, includes simultaneously displaying a first keyboard on a first region and a second keyboard including second keyboard language selection keys on a second region by the touchscreen in a character inputting mode; and changing a language of the second keyboard to a language corresponding to a second touched keyboard language selection key touched while maintaining a language of the first keyboard when input touching the second keyboard language key is received.

    摘要翻译: 提供了一种用于提供字符输入接口的方法和装置。 用于在具有触摸屏的终端中提供字符输入接口的方法包括:以字符输入模式,通过触摸屏同时显示第一区域上的第一键盘和包括第二区域上的第二键盘语言选择键的第二键盘; 以及当接收到接触到所述第二键盘语言密钥的输入时,将所述第二键盘的语言改变为对应于所触摸的第二触摸键盘语言选择键的语言,同时保持所述第一键盘的语言。

    Text input method in portable device and portable device supporting the same
    5.
    发明授权
    Text input method in portable device and portable device supporting the same 有权
    便携式设备中的文本输入法和支持相同的便携式设备

    公开(公告)号:US08799779B2

    公开(公告)日:2014-08-05

    申请号:US13042696

    申请日:2011-03-08

    摘要: A text input method in a portable device and a portable device supporting the same are provided. The portable device includes, a touch screen including a display unit for displaying a text input area and a text display area including at least one consonant and vowel, and a touch panel provided at an upper side of the display unit for generating a touch event, and a control unit for controlling text displayed according to a touch event generated from the touch screen, in which the control unit detects multi-touch events for at least two key icons output on the text input area, and controls the display of a specific text composed of a combination of the multi-touched key icons based on the detected multi-touch events.

    摘要翻译: 提供了便携式设备中的文本输入方法和支持它的便携式设备。 便携式设备包括:触摸屏,其包括用于显示文本输入区域的显示单元和包括至少一个辅音和元音的文本显示区域;以及设置在所述显示单元的上侧以产生触摸事件的触摸面板, 以及控制单元,用于控制根据从触摸屏产生的触摸事件显示的文本,其中控制单元检测在文本输入区域上输出的至少两个键图标的多点触摸事件,并且控制特定文本的显示 由基于检测到的多点触摸事件的多点触摸的键图标的组合构成。

    N1-Cyclic Amine-N5-Substituted Phenyl Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same
    7.
    发明申请
    N1-Cyclic Amine-N5-Substituted Phenyl Biguanide Derivatives, Methods of Preparing the Same and Pharmaceutical Composition Comprising the Same 有权
    N1环状胺-N5取代苯基双胍衍生物,其制备方法和药物组合物

    公开(公告)号:US20140179660A1

    公开(公告)日:2014-06-26

    申请号:US14237514

    申请日:2012-08-08

    摘要: An N1-cyclic amine-N5-substituted phenyl biguanide derivative of Formula 1 or a pharmaceutically acceptable salt thereof, a method of manufacturing the same, and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an active ingredient are provided. The biguanide derivatives have an effect of inhibiting cancer cell proliferation and also exhibit anticancer activity including inhibition of cancer metastasis and cancer recurrence, because they are effective in activating AMPK, which is associated with the control of energy metabolism, even when administered in a small dose compared with conventional drugs. Also, the biguanide derivatives are highly effective at lowering blood glucose and lipid concentration by AMPK activation, thus they may be effectively used to treat diabetes mellitus, obesity, hyperlipemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovary syndrome and metabolic syndrome.

    摘要翻译: 提供式1的N 1 - 环胺-N 5 - 取代的苯基双胍衍生物或其药学上可接受的盐,其制备方法和包含双胍衍生物或其药学上可接受的盐作为活性成分的药物组合物。 双胍衍生物具有抑制癌细胞增殖的作用,并且还表现出抗肿瘤活性,包括抑制癌症转移和癌症复发,因为即使以小剂量施用也能有效地激活与能量代谢控制有关的AMPK 与常规药物相比。 此外,双胍衍生物通过AMPK活化降低血糖和脂质浓度高度有效,因此可有效用于治疗糖尿病,肥胖症,高脂血症,高胆固醇血症,脂肪肝,冠状动脉疾病,骨质疏松症,多囊卵巢综合征和代谢 综合征

    N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same
    9.
    发明授权
    N1-cyclic amine-N5-substituted phenyl biguanide derivatives, methods of preparing the same and pharmaceutical composition comprising the same 有权
    N 1 - 环胺-N 5取代的苯基双胍衍生物,其制备方法和包含其的药物组合物

    公开(公告)号:US09540325B2

    公开(公告)日:2017-01-10

    申请号:US14237514

    申请日:2012-08-08

    摘要: An N1-cyclic amine-N5-substituted phenyl biguanide derivative of Formula 1 or a pharmaceutically acceptable salt thereof, a method of manufacturing the same, and a pharmaceutical composition including the biguanide derivative or the pharmaceutically acceptable salt thereof as an active ingredient are provided. The biguanide derivatives have an effect of inhibiting cancer cell proliferation and also exhibit anticancer activity including inhibition of cancer metastasis and cancer recurrence, because they are effective in activating AMPK, which is associated with the control of energy metabolism, even when administered in a small dose compared with conventional drugs. Also, the biguanide derivatives are highly effective at lowering blood glucose and lipid concentration by AMPK activation, thus they may be effectively used to treat diabetes mellitus, obesity, hyperlipemia, hypercholesterolemia, fatty liver, coronary artery disease, osteoporosis, polycystic ovary syndrome and metabolic syndrome.

    摘要翻译: 提供式1的N 1 - 环胺-N 5 - 取代的苯基双胍衍生物或其药学上可接受的盐,其制备方法和包含双胍衍生物或其药学上可接受的盐作为活性成分的药物组合物。 双胍衍生物具有抑制癌细胞增殖的作用,并且还表现出抗肿瘤活性,包括抑制癌症转移和癌症复发,因为即使以小剂量施用也能有效地激活与能量代谢控制有关的AMPK 与常规药物相比。 此外,双胍衍生物通过AMPK活化降低血糖和脂质浓度高度有效,因此可有效用于治疗糖尿病,肥胖症,高脂血症,高胆固醇血症,脂肪肝,冠状动脉疾病,骨质疏松症,多囊卵巢综合征和代谢 综合征